| 2025-11-04 |
详情>>
股本变动：
变动后总股本18336.25万股
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.11美元,归母净利润-1724.1万美元,同比去年增长0.01%
|
| 2025-11-04 |
财报披露：
美东时间 2025-11-04 盘前发布财报
|
| 2025-09-19 |
股东大会：
将于2025-10-13召开股东大会
会议内容 ▼▲
- 1.To approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of a number of shares of the Company’s Common Stock in connection with the conversion of convertible senior unsecured promissory notes due 2031 held by several non-affiliated purchasers, which could, under certain circumstances that may occur in the future, exceed 19.99% of the number of shares of the Company’s Common Stock issued and outstanding prior to such issuance;
2.To approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of a number of shares of the Company’s Common Stock in connection with the conversion of the Company’s Series A Convertible Preferred Stock held by several non-affiliated holders, which could, under certain circumstances that may occur in the future, exceed 19.99% of the number of shares of the Company’s Common Stock issued and outstanding prior to such issuance.
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益0.00美元,归母净利润25.40万美元,同比去年增长102.05%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益0.02美元,归母净利润263.50万美元,同比去年增长183.39%
|
| 2025-04-30 |
股东大会：
将于2025-06-12召开股东大会
会议内容 ▼▲
- 1.To elect six director nominees named in the enclosed Proxy Statement to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal;
2.To ratify the appointment of Withum Smith+Brown, PC (“Withum”) as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers for the fiscal year ended December 31, 2024;
4.To approve, on a nonbinding advisory basis, the frequency of future advisory votes on the compensation paid to our Named Executive Officers;
5.To transact such other business as may properly come before the Annual Meeting.
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益-0.09美元,归母净利润-1358万美元,同比去年增长87.72%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.11美元,归母净利润-1724.3万美元,同比去年增长82.73%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-0.08美元,归母净利润-1239.5万美元,同比去年增长83.44%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.02美元,归母净利润-316万美元,同比去年增长90.36%
|
| 2024-04-29 |
股东大会：
将于2024-06-13召开股东大会
会议内容 ▼▲
- 1.To elect six director nominees named in the accompanying Proxy Statement to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Withum Smith+Brown, PC (“Withum”) as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers during the fiscal year ended December 31, 2023;
4.To amend the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”) to increase the aggregate number of authorized shares of the Company’s common stock, par value $0.01 per share (“common stock”) by 175,000,000 from 225,000,000 to 400,000,000;
5.To amend the Company’s 2007 Amended and Restated Equity Incentive Plan (the “2007 Plan”), to increase the number of shares of common stock authorized for issuance thereunder by 7,500,000 from 39,190,000 to 46,690,000;
6.To amend the Company’s 1997 Employee Stock Purchase Plan, as amended (the “ESPP”), to increase the number of shares of common stock authorized for issuance thereunder by 1,200,000 from 2,225,000 to 3,425,000;
7.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2024-03-12 |
详情>>
业绩披露：
2023年年报每股收益-0.8美元,归母净利润-1.11亿美元,同比去年增长39.26%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.75美元,归母净利润-9983.5万美元,同比去年增长38.43%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-0.63美元,归母净利润-7482.7万美元,同比去年增长37.77%
|
| 2023-05-01 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect seven director nominees named in the accompanying Proxy Statement to serve until the 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Withum Smith+Brown, PC as our independent registered public accounting firm for the year ending December 31, 2023;
3.To approve, on an advisory basis, compensation paid to our Named Executive Officers during the year ended December 31, 2022;
4.To amend the Company’s Certificate of Incorporation to increase the aggregate number of authorized shares of common stock by 75,000,000 from 150,000,000 to 225,000,000;
5.To amend the Company’s 2007 Amended and Restated Equity Incentive Plan (the “2007 Plan”) to increase the number of shares of common stock authorized for issuance thereunder from 30,700,000 to 39,190,000;
6.To amend the Company’s 1997 Employee Stock Purchase Plan, as amended (the “ESPP”) to increase the number of shares of common stock authorized for issuance thereunder from 1,825,000 to 2,225,000;
7.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-04-25 |
股东大会：
将于2022-05-24召开股东大会
会议内容 ▼▲
- 1.To elect seven director nominees named in the accompanying Proxy Statement to serve until the 2023 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Withum Smith+Brown, PC as our independent registered public accounting firm for the year ending December 31, 2022;
3.To approve, on an advisory basis, compensation paid to our Named Executive Officers during the year ended December 31, 2021;
4.To amend the Company’s Certificate of Incorporation to increase the aggregate number of authorized shares of common stock by 100,000,000 from 150,000,000 to 250,000,000;
5.To amend the Company’s 2007 Amended and Restated Equity Incentive Plan (the “2007 Plan”) to increase the number of shares of common stock authorized for issuance thereunder from 27,800,000 to 30,700,000;
6.To amend the Company’s 1997 Employee Stock Purchase Plan, as amended (the “ESPP”) to increase the number of shares of common stock authorized for issuance thereunder from 975,000 to 1,825,000;
7.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-22 |
股东大会：
将于2021-06-17召开股东大会
会议内容 ▼▲
- 1.To elect five director nominees named in the accompanying Proxy Statement to serve until the 2022 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of OUM & Co. LLP as our independent registered public accounting firm for the year ending December 31, 2021;
3.To approve, on an advisory basis, compensation paid to our Named Executive Officers during the year ended December 31, 2020;
4.To amend the Company’s 2007 Amended and Restated Equity Incentive Plan (the “2007 Plan”) to increase the number of shares of common stock authorized for issuance thereunder from 25,800,000 to 27,800,000;
5.To amend the Company’s 1997 Employee Stock Purchase Plan, as amended (the “ESPP”) to increase the number of shares of common stock authorized for issuance thereunder from 775,000 to 975,000;
6.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-04-23 |
股东大会：
将于2020-06-17召开股东大会
会议内容 ▼▲
- 1.To elect seven director nominees named in the accompanying Proxy Statement to serve until the 2021 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of OUM & Co. LLP as our independent registered public accounting firm for the year ending December 31, 2020;
3.To approve, on an advisory basis, compensation paid to our Named Executive Officers during the year ended December 31, 2019;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2019-04-26 |
股东大会：
将于2019-06-18召开股东大会
会议内容 ▼▲
- 1.To elect five director nominees named in the accompanying Proxy Statement to serve until the 2020 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of OUM & Co. LLP as our independent registered public accounting firm for the year ending December 31, 2019;
3.To approve, on an advisory basis, compensation paid to our Named Executive Officers during the year ended December 31, 2018;
4.To approve, on an advisory basis, the frequency of future advisory votes to approve compensation paid to our Named Executive Officers;
5.To amend the Company’s 2007 Amended and Restated Equity Incentive Plan (the “2007 Plan”) to increase the number of shares of common stock authorized for issuance thereunder from 18,800,000 to 25,800,000;
6.To amend the Company’s 1997 Employee Stock Purchase Plan, as amended (the “ESPP”) to increase the number of shares of common stock authorized for issuance thereunder from 475,000 to 775,000;
7.To transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2018-04-30 |
股东大会：
将于2018-06-18召开股东大会
会议内容 ▼▲
- 1.To elect six director nominees named in the accompanying Proxy Statement to serve until the 2019 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of OUM & Co. LLP as our independent registered public accounting firm for the year ending December 31, 2018;
3.To approve, on an advisory basis, compensation paid to our named executive officers during the year ended December 31, 2017;
4.To amend the Company’s Certificate of Incorporation to increase the aggregate number of authorized shares of common stock by 50,000,000;
5.To transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2017-04-26 |
股东大会：
将于2017-06-12召开股东大会
会议内容 ▼▲
- 1.To elect six director nominees named in the accompanying Proxy Statement, to serve until the 2018 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of OUM & Co. LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3.To approve, on an advisory basis, fiscal 2016 compensation paid to our named executive officers;
4.To amend the Company’s Certificate of Incorporation to increase the aggregate number of authorized shares of common stock by 25,000,000;
5.To amend the Company’s 2007 Amended and Restated Equity Incentive Plan (the “2007 Plan”) to increase the number of shares of common stock authorized for issuance thereunder from 13,800,000 to 18,800,000;
6.To amend the Company’s 1997 Employee Stock Purchase Plan, as amended (the “ESPP”) to increase the number of shares of common stock authorized for issuance thereunder from 275,000 to 475,000;
7.To transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2016-04-29 |
股东大会：
将于2016-06-21召开股东大会
会议内容 ▼▲
- 1.To elect five director nominees named in the accompanying Proxy Statement, to serve until the 2017 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of OUM & Co. LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
3.To approve, on an advisory basis, fiscal 2015 compensation paid to our named executive officers;
4.To amend the Company’s 2007 Amended and Restated Equity Incentive Plan (the “2007 Plan”) to increase the shares of common stock authorized for issuance thereunder from 10,800,000 to 13,800,000;
5.To amend the Company’s 1997 Employee Stock Purchase Plan, as amended (the “ESPP”) to increase the shares of common stock authorized for issuance thereunder from 175,000 to 275,000;
6.To transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|